CIK 0001787400 · Non-accelerated filer<br>Smaller reporting company
Nkarta, Inc.
Sign in to watch- Ticker
- NKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474515206
- Phone
- (925) 407-1049
- Business address
- 1150 VETERANS BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 84 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-13 | PATTERSON LEONE D Director | Grant or award · Stock Option (right to buy) | +22,500 | 22,500 | ||
| 2024-06-13 | Dybbs Michael Director | Grant or award · Stock Option (right to buy) | +22,500 | 22,500 | ||
| 2024-06-13 | Thedinga Angela Director | Grant or award · Stock Option (right to buy) | +22,500 | 22,500 | ||
| 2024-06-13 | Vratsanos George Director | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2024-03-27 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +3,000,000 | $10.00 | $30.0M | 10,050,818 |
| 2024-03-27 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase · Pre- Funded Warrants (Right to Buy) | +3,000,031 | $10.00 | $30.0M | 3,000,031 |
| 2024-03-27 | George Simeon Director | Purchase | +1,548,341 | $10.00 | $15.5M | 1,548,341 |
| 2024-03-27 | George Simeon Director | Purchase | +451,659 | $10.00 | $4.5M | 451,659 |
| 2024-03-04 | HASTINGS PAUL J Chief Executive Officer | Returned to the company | −137,642 | $13.33 | $1.8M | 240,507 |
| 2024-03-01 | HASTINGS PAUL J Chief Executive Officer | Returned to the company | −12,358 | $13.00 | $161K | 378,149 |
| 2024-03-01 | Brandenberger Ralph Chief Technical Officer | Option exercise | +3,808 | $3.89 | $15K | 85,384 |
| 2024-03-01 | Brandenberger Ralph Chief Technical Officer | Option exercise | +2,955 | $3.89 | $11K | 88,339 |
| 2024-03-01 | Brandenberger Ralph Chief Technical Officer | Sale | −8,367 | $12.51 | $105K | 79,972 |
| 2024-03-01 | Brandenberger Ralph Chief Technical Officer | Option exercise · Stock Option (right to buy) | −3,808 | 22,445 | ||
| 2024-03-01 | Brandenberger Ralph Chief Technical Officer | Option exercise · Stock Option (right to buy) | −2,955 | 25,629 | ||
| 2024-02-12 | Trager James Chief Scientific Officer | Sale | −4,143 | $12.00 | $50K | 149,415 |
| 2024-01-16 | Shook David Chief Medical Officer | Sale | −3,552 | $8.74 | $31K | 114,980 |
| 2024-01-16 | Trager James Chief Scientific Officer | Sale | −4,560 | $8.74 | $40K | 153,558 |
| 2024-01-16 | Brandenberger Ralph Chief Technical Officer | Sale | −2,512 | $8.74 | $22K | 81,576 |
| 2024-01-16 | HASTINGS PAUL J Chief Executive Officer | Sale | −9,697 | $8.74 | $85K | 390,507 |
Page 4 of 8 · 159 trades